Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
66.4M
-
Shares change
-
+6.98M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$212M
-
Put/Call ratio
-
0.27
-
Number of buys
-
134
-
Number of sells
-
-100
-
Price
-
$29.62
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2017
263 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2017.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.4M shares
of 115M outstanding shares and own 57.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.39M shares), WELLINGTON MANAGEMENT GROUP LLP (6.73M shares), VANGUARD GROUP INC (5.64M shares), Consonance Capital Management LP (2.94M shares), Bank of New York Mellon Corp (2.63M shares), STATE STREET CORP (2.25M shares), JANUS CAPITAL MANAGEMENT LLC (1.98M shares), Van Berkom & Associates Inc. (1.97M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (1.89M shares), and DIMENSIONAL FUND ADVISORS LP (1.83M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.